Posts

historic vaccine rolloutThe African Union (AU) has announced a deal that will send up to 400 million vaccines to 55 member states. The vaccines will go across the African continent in monthly shipments in order to fight the COVID-19 pandemic.

On August 5, 2021, Cyril Ramaphosa, the President of the Republic of South Africa made this historic vaccine rollout public. He reported that the AU had purchased 220 million doses of Johnson & Johnson’s COVID-19 vaccine in March. A possible 180 million additional vaccines can later be ordered.

How was the deal made?

In light of the COVID-19 pandemic, the African Union joined forces with the World Bank and other organizations to support The African Vaccine Acquisition Task Team. The team aims to provide rapid access to doses of the vaccine for the people of Africa. The team comprises ten members, including political leaders, health ministers, businessmen and philanthropists from all across Africa.

The World Bank will continue to support the AU in this historic vaccine rollout, supplying resources that will allow individual nations to purchase and distribute the vaccine. Additional assistance will come from the United Nations. UNICEF will assist with delivery and distribution management across the African continent.

Why Johnson & Johnson?

Each of the 400 million doses included in the deal will come from Johnson & Johnson.

The calculus behind this decision was thorough: Since the vaccine comes in a single dose, it is easier and cheaper to produce and administer. Moreover, the vaccine’s relatively long shelf life will ease logistical concerns. A recent study from South Africa reported high efficacy for the single-shot J&J vaccine, with up to 96.2 percent protection against death. The study also reported high protection against both the Delta and Beta variants of COVID-19 in Africa.

The most significant piece of the vaccine deal will take place right at home—part of the vaccine manufacturing process will occur in South Africa. Centralized at the Aspen Pharmacare facility in Gqeberha, South Africa, this insourcing of production will provide new jobs that will, in part, assist with post-pandemic economic recovery.

Where Africa Stands

As a continent, Africa lags behind in vaccination rates, which has placed economic stress on many nations. Vaccination rates also exemplify pandemic inequities that permeate the globe. As of July 23, 2021, only 2.2 percent of the African population has received a dose of any vaccine. In North America, more than half the population has received at least one shot.

These 400 million doses are enough to immunize more than one-third of the African population. At the same time, more work will need to take place in order for the continent to reach its 60% goal as it continues to adapt to and fight against the pandemic.

This new deal to bring in and produce vaccines provides hope that cases and deaths related to COVID-19 in Africa can decrease. It also helps cement the hope that even some of the most impoverished areas in Africa can recover from the pandemic.

Sam Dils
Photo: Wikimedia Commons

diarrheal disease in sub-saharan africaEvery year, millions of children under the age of 5 die. Of those children, almost 40% come from Africa. The chance of death for a child living in Africa is seven times higher than that of a child in Europe. This marks the need for improved medical care and foreign aid, especially because many of these deaths are caused by diarrheal diseases. Diarrheal diseases are the second highest cause of death around the world, with over 1.5 million deaths each year. While any country’s children can be susceptible to this illness, developing countries have a marked disadvantage. Many of the countries in sub-Saharan Africa, where the disease is prevalent, don’t have access to proper sanitation, clean water or viable medical care. Here are five facts about diarrheal diseases in sub-Saharan Africa.

5 Facts About Diarrheal Diseases in Sub-Saharan Africa

  1. Mortality varies greatly by region. There is a higher prevalence of diarrheal diseases in sub-Saharan Africa, but especially in impoverished nations. Additionally, within sub-Saharan Africa, certain countries have much higher mortality rates than others due to these diseases. More than half of the global deaths that occurred in 2015 due to diarrheal diseases came from just 55 African provinces or states out of the total 782 that exist.
  2. The problem is partially economic. Diarrheal diseases don’t only impact the health of these countries’ citizens, but they also take a massive toll on the economy. An estimated 12% of governmental budgets go toward treating these diseases in some countries. Moreover, the World Bank estimates that almost 10% of these nations’ total GDP goes toward the treatment of these health issues. Individual members of each country also feel the monetary blow of obtaining treatment. In many of these countries, the salary of the average citizen is around $1.00 a day. One Kenyan mother named Evalyne was unable to save her son from a diarrheal disease because she couldn’t afford the $0.25 needed for oral rehydration therapy.
  3. There are more victims of these diseases than just children. A lot of the information about diarrheal diseases in sub-Saharan Africa focuses on children under the age of five. However, people over the age of 70 are also very susceptible to diarrheal diseases. The demographics of these two groups are unique. Most children die from diarrheal diseases in Chad, the Central African Republic and Niger. Nevertheless, most elderly people die from diarrheal disease in Kenya, the Central African Republic and India. The differences don’t end there. Most children who contract a diarrheal disease are plagued by the rotavirus, but the elderly have proven to be most prone to another virus named shigella.
  4. The diseases are treatable and even preventable with the right precautions. There are many precautions that can be taken to avoid catching diarrheal diseases in sub-Saharan Africa. One of the most important preventative actions is to do everything possible to consume clean water. Around the world, 40% of the population doesn’t have easy access to adequate sanitation. Many children and adults don’t have soap to wash their hands with after using the bathroom, and oftentimes, the water they use is contaminated. Washing one’s hands and working to improve local water supplies can drastically improve one’s chances against diarrheal diseases. Treating citizens with supplements like zinc and vitamin A can also lessen the severity of diarrheal episodes. Other than supplements and better water, oral rehydration therapy is a great way to treat the illness. Families can use oral rehydration at home by combining salt, sugar and clean water to prevent crippling dehydration. Another potential solution is a rotavirus vaccine.
  5. Education and competition can change the future. In some countries, access to clean water and proper sanitation seems impossible. However, providing communities with the resources and knowledge of how to improve sanitation and lower the risk of diseases has demonstrated that change is possible. In Cameroon, the World Wildlife Fund partnered with Johnson and Johnson to provide training and resources to the members of various communities. This helped them build more sanitary bathrooms and create new and viable water sources. One reason that these programs were so successful is that they created competitions among villages. This became a friendly way of motivating each other toward success.

Diarrheal diseases in sub-Saharan Africa continue to plague areas without clean water or access to healthcare. However, as time goes on, more and more programs and organizations aid in the control of these illnesses. For example, since 2018, ROTAVAC, a rotavirus vaccine, was prequalified by the World Health Organization for use in Ghana. This qualification is specifically focused on providing vaccines to those in countries without easy access to vaccination. Ghana is now the second country in Africa to place ROTAVAC as part of its program to immunize citizens against diarrheal disease. Doing this raises awareness across regions about a future where disease prevention is all the more possible.

Lucia Kenig-Ziesler
Photo: Flickr